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α-Synuclein (α-syn) is a 140-amino acid protein that playsa central role in the pathogenesis of Parkinson’s disease
(PD) and other synucleinopathies. The oligomerization and/or
ﬁbrillogenesis of α-syn are thought to be primary causes of the
loss of dopamine producing neurons in the substantia nigra pars
compacta of PD brains and the formation of the cytoplasmic
inclusions, known as Lewy bodies (LBs), that are the main
pathological feature of the disease.14 However, the molecular
determinants responsible for triggering and/or propagating α-
syn aggregation and toxicity remain poorly understood. Several
studies have demonstrated direct interactions between diﬀerent
metals and α-syn,510 but the molecular mechanisms by which
α-syn interactions with metals inﬂuence its role in the pathogen-
esis of PD is not yet ﬁrmly established.11 Metal interactions with
α-syn have been reported to inﬂuence the structure and pro-
pensity for aggregation of α-syn in vitro and in cell culture
models of synucleinopathies. Systematic studies by Uversky and
colleagues9 have identiﬁed a number of monovalent (Li(I), K(I),
Na(I), and Cs(I)), divalent (Ca(II), Co(II), Cd(II), Cu(II),
Fe(II), Mg(II), Mn(II), Zn(II)), and trivalent (Al(III), Co(III),
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ABSTRACT: α-Synuclein (α-syn) is a 140-amino acid protein that plays a
central role in the pathogenesis of Parkinson’s disease (PD) and other
synucleinopathies. However, the molecular determinants that are responsible
for triggering and/or propagating α-syn aggregation and toxicity remain poorly
understood. Several studies have suggested that there are direct interactions
between diﬀerent metals and α-syn, but the role of metal ions and α-syn in the
pathogenesis of PD is not ﬁrmly established. Interestingly, the majority of
disease-associated post-translational modiﬁcations (PTMs) (e.g., truncation,
phosphorylation, and nitration) of α-syn occur at residues within the C-term-
inal region (Y125, S129, Y133, and Y136) and in very close proximity to the
putative metal binding sites. Therefore, we hypothesized that phosphorylation
within this domain could inﬂuence theα-synmetal interactions. In this paper,
we sought tomap the interactions between the di- and trivalent cations, Cu(II),
Pb(II), Fe(II), and Fe(III), and the C-terminal region of α-syn encompassing residues 107140 and to determine how
phosphorylation at S129 or Y125 alters the speciﬁcity and binding aﬃnity of metals using electrospray ionization-mass spectrometry
(ESI-MS) and ﬂuorescence spectroscopy. We demonstrate that D115-M116 and P128-S129 act as additional Cu(II) binding sites
and show for the ﬁrst time that the residues P128-S129 and D119 are also involved in Pb(II) and Fe(II) coordination, although
D119 is not essential for binding to Fe(II) and Pb(II). Furthermore, we demonstrate that phosphorylation at either Y125 or S129
increases the binding aﬃnity of Cu(II), Pb(II), and Fe(II), but not Fe(III). Additionally, we also show that phosphorylations at these
residues lead to a shift in the binding sites ofmetal ions from theN-terminus to the C-teminus. Together, our ﬁndings provide critical
insight into and expand our understanding of the molecular and structural bases underlying the interactions between α-syn and
metal ions, including the identiﬁcation of novel metal binding sites, and highlight the potential importance of cross-talk between
post-translational modiﬁcations and metal ion binding in modulating α-syn functional and aggregation properties that are regulated
by its C-terminal domain.
KEYWORDS: α-Synuclein, metal ion, binding, C-terminal, phosphorylation, mass spectrometry
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and Fe(III)) cations that signiﬁcantly accelerate α-syn ﬁbrilliza-
tion in vitro under physiological conditions, with Cu(II), Co(II),
Al(III), and Fe(III) being the most eﬀective in enhancing α-syn
ﬁbrillization. A potential mechanism behind the enhanced amy-
loid formation is the stabilization of partially folded, on-pathway
oligomeric intermediates characterized by an increase in the
secondary structure content and changes in the local environ-
ment near the tyrosine residues. Indeed, a more recent report by
Kostka and colleagues supports this hypothesis. In their study,
small oligomers were generated ﬁrst by incubation with organic
solvents. It was shown that Fe(III) speciﬁcally induced the for-
mation of larger oligomeric species which resisted SDS-induced
dissociation and could form pores as assessed by conductance
assays in a planar bilayer setup. Importantly, these oligomers
were demonstrated to be on-pathway to amyloid ﬁbril forma-
tion.12 In the case of polyvalent cations, the aggregation mechan-
ism might also include intermolecular bridging between metal
anchoring sites. However, the precise mechanism by which metal
ions regulate α-syn aggregation may also be unique for each metal
ion, as is suggested by the diﬀerent α-syn ﬁbril morphologies
observed with the coincubation of α-syn with various metals.13
Several studies have demonstrated that the C-terminal domain
(residues 107140) plays a central role in regulating the inter-
actions of α-syn with metals. For example, it has been shown to
bind several divalent cations, Fe(II), Mn(II), Co(II), and Ni(II),
although the low (mM) binding aﬃnities suggest a purely
electrostatic, nonspeciﬁc mode of interaction.6 Cu(II), which
has been shown to bind primarily to the C-terminus of α-syn, is
one of the most potent inducers of α-syn multimerization.8 In
another study, coincubation of α-syn with Mn(II) resulted in the
immediate formation of dityrosine cross-links.9 Although the
binding site of Mn(II) to α-syn has not yet beenmapped, the fact
that most of the tyrosine residues inα-syn (Y39, Y125, Y133, and
Y136) are clustered in the C-terminal region strongly suggests
that it could be the primary Mn(II) interaction domain. The
formation of intermolecular dityrosines has been proposed as a
possible event in the initiation ofα-syn ﬁbrillization. Oxidation of
methionine residues to the sulfoxide form creates additional
metal coordination sites that dramatically alterα-syn interactions
with metals and its ﬁbrillization in vitro. For example, it has been
proposed that intermolecular metal coordination involving two
or moremethionine sulfoxides could promoteα-syn ﬁbrillization
via a metal bridging mechanism.14 The C-terminus of α-syn
contains twomethionine residues, M116 andM127, which could
be involved in such metal interactions. Moreover, their proximity
to known phosphorylation sites indicates a potential interplay
between C-terminal phosphorylation and methionine oxidation
in regulating α-syn interactions with metals.
Interestingly, the majority of disease-associated post-transla-
tional modiﬁcations (PTMs) (e.g., truncation, phosphorylation,
and nitration) in α-syn occur at residues within the C-terminal
region (Y125, S129, Y133, and Y136) and in very close proximity
to the putative metal binding sites. Despite the detection of most
of these modiﬁcations within LBs, recent studies from our group
and others have shown that phosphorylation at S87 or S129 and
ubiquitination alter the conformational ﬂexibility of monomeric
α-syn and block, rather than promote, its ﬁbrillization.15,16 These
ﬁndings suggest that those α-syn PTMs are not required for
α-syn aggregation and LB formation. The high degree of ﬂex-
ibility of the C-terminus in the monomeric and aggregated states
of the protein combined with its implication inα-syn interactions
with other proteins,5,1719 ligands, and metal ions suggests that
post-translational modiﬁcations within this region could signiﬁ-
cantly inﬂuence these interactions and may contribute to reg-
ulating α-syn function in health and disease.
In this paper, we sought to map the interactions between
diﬀerent metal ions and the C-terminal region of α-syn encom-
passing residues 107140 and to determine how disease-asso-
ciated phosphorylations alter the speciﬁcity and binding aﬃnity
of these metal ions using electrospray ionization-mass spectro-
metry (ESI-MS), which is a suitable tool for studying bioinor-
ganic complexes.2023 This technique provides information on
binding sites, possible modiﬁcations (oxidations, cross-linking,
and truncation), and also relative binding aﬃnities.2429 More
speciﬁcally, we focused on the interactions between Cu(II),
Pb(II), Fe(II), and Fe(III) ions and the C-terminal fragment
α-syn(107140) (wild-type, wt) and its phosphorylated forms
on residues Y125 (pY125) and S129 (pS129). Moreover, the
dissociation constants (Kd) were determined based on tyrosine
ﬂuorescence.
’RESULTS AND DISCUSSION
Comparison of C-Terminal α-Synuclein Binding to Differ-
ent Metals. Divalent and trivalent cations (e.g., Cu(II), Pb(II),
and Fe(III)) have been shown to act as important regulators ofα-
syn aggregation and are thought to contribute directly or
indirectly to the mechanisms underlying neurodegeneration in
PD.30,31 For example, post-mortem analysis of the brains of PD
patients shows a characteristic increase in Fe(III) with respect to
Fe(II). Fe(III) has been implicated in selective dopaminergic
neuronal death. Youdim and colleagues showed that injection of
FeCl3 into the substantia nigra of rats results in >90% loss of
striatal dopamine.32 Furthermore, Fe(II) is involved in reactive
oxygen species (ROS) production via Fenton chemistry and
peroxynitrite formation.33,34 Tabner et al. demonstrated the
accumulation of hydrogen peroxide during the incubation of
α-syn in PBS and the production of hydroxyl radicals with the
addition of Fe(II).30 Lead is a well-known toxic heavy metal that
is associated with several neurodegenerative disorders, including
PD: Coon et al. studied 121 PD patients and showed that
occupational lead exposure is a risk factor for PD.35 Part of the
toxic response to Pb(II) exposure is the formation of aggresome-
type inclusions in target cells, a process which was shown to be
controlled by α-syn, among other proteins.36 Because copper is
redox-active in the brain, it has been hypothesized that dysregu-
lation of copper homeostasis, for example, through abnormal
binding to α-syn, could catalyze the formation of noxious ROS
and thus contribute to neurodegeneration via increased oxidative
stress.37 α-syn itself can become oxidized by a copper-catalyzed
reaction resulting in the formation of SDS-resistant oligomers.38
Rasia et al. showed that copper accelerates α-syn aggregation
under physiological conditions without altering the morphology
of its fibrillar structures,10 and Wang et al. identified α-syn
oligomeric species that require the presence of copper to induce
cell death.39
In this study, we investigated the complexation of C-terminal
α-syn(107140) (wild-type, wt) with metal ions such as Cu(II),
Pb(II), Fe(II), and Fe(III) by ESI-MS. As shown in Figure 1a,
triply charged wt-Cu(II) complexes were clearly observed at
m/z = 1307.7 Th in a high abundance with the addition of a 5-fold
concentration of Cu(II). At lower concentrations of Cu(II),
α-syn-Cu(II) complexes were not observed. The isotopic dis-
tribution of the triply charged ions was also examined and was
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found to match that of the theoretical triply charged wt-Cu(II)
complexes. This result demonstrates the existence of Cu(II)
complexes to C-terminal α-syn and also suggests that C-terminal
α-syn has a relatively weak binding aﬃnity to Cu(II), consistent
with previous reports using shorter C-terminal peptide fragments
(deleted residues).10,40
To determine the binding site of Cu(II) to α-syn(107140),
tandem mass spectrometry (MS/MS) using collision-induced
dissociation (CID) was applied. This method allows one to
obtain information on structure and to determine binding
sites.20,23 Once selected in a trap, the gas-phase ion (the peptide)
is accelerated and gains internal energy by collision with helium
gas. The extra internal energy is redistributed along its vibrational
modes, which results in the peptide fragmentation. Interestingly,
the fragmentation occurs at the peptide bonds, the cleavages of
which lead to the generation of b- and y-type fragments (N-
terminal and C-terminal, respectively).41,42 Because metal ions
interacting with the peptides prior to their introduction into the
mass spectrometer remain bound on the fragments after CID, the
residue(s) to which the metal ion binds can be determined by a
careful identiﬁcation of the b- and y-type of ions complexed or
not with the metal ion. As shown in Figure 1b, the fragments of
triply charged wt-Cu(II) complexes with at least 4% relative
abundance were identiﬁed and the fragments bound with Cu(II)
were assigned (marked with asterisks).
The absence of b6*, b7*, and b8* indicates that the ﬁrst eight
residues are not involved in the binding. The presence of b9* is
diﬃcult to determine because of an overlap between y8 and b9*.
Then, owing to the coexistence of b6, b7, b8, b9, and b10*, residues
D115-M116 were considered involved in the binding of Cu(II).
Both the carboxyl moiety of the aspartic acid side chain and the
sulfur of methionine are able to coordinate Cu(II), and hence, it
is diﬃcult to exclude either of these residues on the basis of these
data. Because b10, b12, and b13 alongwith b10*, b12*, and b13* were
produced by CID, the binding site in D115-M116 may not be
very stable. The absence of y7*, y9*, and y11* excludes the
possibility of Cu(II) binding to the last 11 residues. Because of
the presence of y7, y9, y11, and y13*, residues P128S129 were
found to be involved in the Cu(II) coordination. However, the
higher abundance of y13 compared to y13* indicates that this
binding region (P128S129) has a lower binding aﬃnity than
D115-M116. In addition, the presence of b18*, b19*, b20*, b21*
y21*, and y22* in high abundance suggests P120-A124 as another
Cu(II) binding region. Together, these results identify three
binding sites of Cu(II) within the C-terminus of α-syn, namely,
D115-M116, P120-A124, and P128S129. It has been proposed
that the electrostatic interaction between negatively charged
carboxylates in the C-terminal region and the positively charged
cations contributed to the formation of complexes.9 The results
obtained by tandemmass spectrometry are partly consistent with
previous studies by Rasia et al. and Binolﬁ et al. They utilized
1H15N heteronuclear single quantum correlation (HSQC)
spectra to characterize a second lower-aﬃnity binding motif for
Cu(II); C-terminal region D119-E123 showed signiﬁcant chemi-
cal shift changes with the addition of Cu(II) and the strongest
change was centered on D121.6,10
In these studies, a region with restricted structural elements
within this fragment was associated with divalent metal ion bind-
ing sites.6 However, our study demonstrates that D115-M116
and P128-S129 act as additional Cu(II) binding sites. Interest-
ingly, both proline and serine are rarely found in metal binding
motifs, and proline has been reported to interfere with metal
binding in thioredoxin fold proteins.43 These ﬁndings suggest
that phosphorylation at S129 may alter the metal binding aﬃnity
and speciﬁcity to the C-terminus of α-syn.
Then, we sought to explore the molecular basis of the complexa-
tion of Pb(II) and Fe(II) with C-terminal α-syn(107140); we
conducted similar studies to those described above for Cu(II).
Mass spectra of Pb(II) and Fe(II) complexes of α-syn(107140)
were observed with a 5-fold metal ion concentration. Tandem
mass spectrometry of triply charged Pb(II)-wt and Fe(II)-wt
complexes was carried out as well. By comparing the fragments
present in these tandem mass spectra, Pb(II) and Fe(II) com-
plexes produced many similar peptide fragments with and with-
out bound metal ions. Our results suggest that Pb(II) and Fe(II)
behaved in a similar way with respect to the binding of α-
syn(107140) and identiﬁed D119, P128S129, and P120-
A124 as Pb(II) and Fe(II) binding sites. (The tandem mass
spectra for each complex are listed in the Supporting In-
formation.) Consistent with our tandem mass spectrometric
data, studies by Binolﬁ et al. revealed sharp changes in chemical
shifts of D121-E123 with the addition of Fe(II) on 1H15N
HSQC spectra and they suggested D119-A124 as a potential
Figure 1. (a) Mass spectrum of C-terminal α-syn(107140) (5 μM
in 50/50 (v/v) MeOH/H2O) in the presence of 25 μM CuCl2.
(b) Tandem mass spectrum of triply charged copper-wt complexes, in
which the selected parent ion is atm/z = 1314.0( 1.7 Th at 22% of relative
collision energy. (Asterisks denote the fragments bound to Cu(II).)
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binding site for Fe(II).6 Furthermore, we show for the ﬁrst time
that the residues P128-S129 andD119 are also involved in Pb(II)
and Fe(II) coordination.
To determine the role of D119 in metal coordination, we
synthesized a C-terminal peptide in which D119 was mutated to
alanine (D119A). The complexes of D119A with Fe(II) and
Pb(II) were observed in the presence of a 5-fold concentration of
metal ions, but not in the presence of a one- or two- fold
concentration of Cu(II). The relative abundance of the formed
complexes was similar to that of wild-type C-terminal peptide,
suggesting additional binding sites besides D119. As expected,
tandem MS of these complexes (see Supporting Information)
revealed that residue A119 in D119A was not involved in the
binding to Fe(II) and Pb(II), as corroborated by the absence of
b13*. The above observations demonstrate that D119 participates
in the binding ofα-syn(107140) of Fe(II) and Pb(II) but is not
essential for binding. Also, themetal ion bound fragments of b18*,
b19*, b20*, and b21* in the above tandem MS further support the
role of P120-A124 in the binding of Fe(II) and Pb(II) and
suggest that this region represents a common binding site for
divalent metal ions.6
The complexation of Fe(III) to C-terminal α-syn(107140)
was then investigated, but wt-Fe(III) complexes were unexpect-
edly not observed. Instead, as shown in Figure 2, triply charged
iron complexes were clearly observed at m/z = 1346.1 Th in a
high abundance, in the presence of an equivalent amount of
Fe(III). The isotopic signature of single or two iron complexes
was compared, and two iron ions were conﬁrmed to be involved
in the composition of these iron complexes. An additional shift of
+59 Th of this triply charged complex compared to triply charged
wt was observed. Considering the high tendency of hydrolysis of
Fe(III) in water, the formation of this iron species bound to wt
was assigned as [Fe2O4H2]
+. Compared to the fact that no
complexes of Cu(II), Pb(II), and Fe(II) had been observed with
an equivalent amount of metal ions present (i.e., equimolar
concentration), the high abundance of hydrated iron oxide
complexes implies a much higher binding aﬃnity. Furthermore,
tandem mass spectrometry of triply charged hydrated iron oxide
complexes was also carried out to identify the binding site of this
hydrated iron oxide as P120-M127 (see the Supporting In-
formation). These ﬁndings are consistent with the absence of
the complexes of Fe(III) and full-length α-syn by ESI-MS that
was reported by Zhou et al.44
Figure 3 summarizes the binding regions of each metal ion to
wild type and phosphorylated C-terminal α-syn(107140). The
underlined residues were clearly identiﬁed as binding sites, while
the boxed residues represent other potential binding sites. On the
basis of the data presented above, the region corresponding to
residues D115-M116 was only involved in the Cu(II) binding.
D119 was conﬁrmed in Pb(II) and Fe(II) bindings, and the
region comprising residues P120-A124 and P128-S129 was in-
volved in the binding of Cu(II), Pb(II), and Fe(II). The binding
site of hydrated iron oxide was located within the P120-M127
region, and the loss of two binding sites, at D119 and P128-S129,
indicated that Fe(III) binds diﬀerently.
Metal Binding to Phosphorylated (pY125 and pS129)
C-Terminal α-Synuclein Fragments. Phosphopeptides possess
strong binding affinities to some metal ions.45 Thus, phosphor-
ylation may alter metal ion affinity and specificity and further
influences the folding, structure, and functional properties of
proteins and peptides. As mentioned above, the majority of
putative (Y133 and Y136) and disease associated (S129 and Y125)
phosphorylation sites in α-syn occur in the C-terminal region
spanning residues 120140, which also contains the regions
involved in mediating α-syn binding to metal ions. Therefore, we
hypothesized that phosphorylations within this domain could
influence theα-synmetal interactions. To date, only a few studies
investigating the effect of phosphorylation on the metal-binding
properties of α-syn have been reported: Liu and Franz have
studied the effect of phosphorylation on metal binding using
short fragments of C-terminal α-syn(119132)46,47 and showed
that the phosphorylation at Y125 dramatically enhanced Tb3+
binding.46 In particular, they indicated that theY125phosphorylated
Figure 2. Mass spectrum of C-terminal α-syn(107140) (5 μM in 50/
50 (v/v) MeOH/H2O) in the presence of 5 μM FeCl3.
Figure 3. Schematic representation of the binding regions of Cu(II),
Pb(II), Fe(II), and Fe(III) to wild type (wt) and phosphorylated
C-terminalα-syn(107140) (pY125 and pS129) obtained from tandem
mass spectrometry. The underlined residues were included in the metal
binding, and residues in the frame contained a putative binding site.
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form of this peptide selectively bound trivalent metal ions such as
Fe3+ and Al3+ over divalent metal ions, and peptide dimerization
induced by trivalent metal ions was observed using ESI-MS,
suggesting a possible mechanism for phosphorylation and metal-
dependent self-assembly of α-syn.46,47
Given that the C-terminal region is very dynamic and involves
multiple potential metal binding sites that are likely to play an
important role in mediating phosphorylation-dependent metal
interactions, we thought that it was important to investigate α-
syn metal interactions using longer C-terminal α-syn fragments
that span the entire C-terminal region 107140. Therefore, we
prepared the monophosphorylated forms (pY125 and pS129) of
α-syn(107140) and determined the eﬀects of the phosphor-
ylation at each residue on the interactions with metal ions.
The complexation of pY125 and pS129 with metal ions, such
as Cu(II), Pb(II), and Fe(II), was studied by ESI-MS using the
same protocols as for the wild-type peptide. Both m/z and
isotopic distributions of the complexes were thoroughly investi-
gated to identify the compositions of these complexes. As
observed with the nonphosphorylated peptide, triply charged
metal complexes were clearly observed in a high abundance with
the addition of a 5-fold excess of metal ions, but not at lower
metal concentrations, suggesting that phosphorylation does not
have a dramatic eﬀect on the binding aﬃnity of pY125 α-
syn(107140) to these metal ions. In addition, distinct com-
plexes of both phosphorylated peptides and hydrated iron oxide
[Fe2O4H2]
+ were observed instead of Fe(III)-peptides in the
presence of an equivalent concentration of FeCl3.
To determine how phosphorylation changes the binding
aﬃnity of α-syn(107140) to the metal ions in this study, we
measured the dissociation constants of the metal ion complexes
for both wild type and phosphorylated α-syn(107140) by a
ﬂuorescence quenching (of tyrosine) assay. Tyrosine-containing
peptides exhibit a maximal ﬂuorescence emission at 309 nm after
an excitation at 280 nm. The presence of metal ions able to bind
such peptides in the vicinity of tyrosine residues quenches the
ﬂuorescence in a concentration-dependent manner. Table 1
summarizes the calculated disscociation constants and the metal
binding capacity per peptide (n) obtained from ﬂuorescence data
according to eq 1. Based to the lower Kd of Fe(III) complexes
with α-syn(107140), Fe(III) ions (in fact [Fe2O4H2]+) dis-
played the highest binding aﬃnity. Consistent with the mass
spectrometry results, hydrated iron oxide complexes were only
well observed in the presence of an equivalent amount of metal
ions. The similarKd of hydrated iron oxide complexes with either
wt or phosphorylated α-syn(107140) (Table 1) indicates that
phosphorylation at either Y125 or S129 does not appear to
impact its binding aﬃnity to Fe(III).
The low Kd of Fe(II) and Fe(III) complexes of both wild type
and phosphorylated α-syn(107140) compared to other metal
ions showed that Fe(II) and Fe(III) have similar binding aﬃnities
to the peptides. These ﬁndings are not consistent with the mass
spectrometry results, which showed that Fe(II) complexes of
wild type and phosphorylated α-syn(107140) could not be
observed even when a 2-fold excess concentration of Fe(II) ions
was used. We assume that the measured Kd for Fe(II) complexes
is susceptible to other chemical reactions. The initial excess
concentration of Fe(II) ions compared to peptides in a pH 7.4
buﬀer is not constant during the ﬂuorescence experiment, as
Fe(II) is easily oxidized to Fe(III) and hydrolyzed to form a
hydrated iron oxide complex, which is a much stronger ligand for
α-syn(107140). Therefore, the binding aﬃnity of Fe(II)
should be much lower than the one measured here. Its binding
aﬃnity may even approach those of Cu(II) and Pb(II), as the
complexes of Fe(II) bound to wild type and phosphorylated α-
syn(107140) could not be observed by mass spectrometry
even when a 2-fold excess metal ions was used similar to Cu(II)
and Pb(II). The Kd of Cu(II) and Pb(II) for both wild type and
phosphorylated α-syn(107140) was determined to be in the
range of 100200 μM, which indicates weak binding abilities of
the peptides. The binding aﬃnities of full-length α-syn to
divalent metal ions, such as Ni(II), Co(II), and Fe(II), have also
been determined, and the reported ca.1 mM Kd is indicative of
similar weak binding abilities.6 In our studies, the lower Kd value
for Fe(II) may be due to the longer C-terminal peptide, and thus,
the binding eﬃciencies of the shorter C-terminal fragments of α-
syn to metal ions were higher than the full-length C-terminal
region because of diﬀerences in the conformational properties for
C-terminal peptides of diﬀerent lengths.48
Phosphorylation at bothY125 and S129 did inﬂuence the binding
aﬃnity for Cu(II), Pb(II), and Fe(II). Kd values of Cu(II), Pb(II),
and Fe(II) complexes with phosphorylated α-syn(107140) were
lower than those with wild type, which suggests that the phosphor-
ylations increase the binding aﬃnities for metal ions. Interestingly,
the position of the phosphorylated residues did not show a sig-
niﬁcant diﬀerence in the binding aﬃnities, and similar Kd values of
the complexes with Cu(II), Pb(II), and Fe(II) were observed for
the two phosphorylated forms pY125 or pS129.
Because Fe(II) could be involved in the pathogenesis of
synucleinopathies through the formation of ROS by Fenton
chemistry, and α-syn has been shown to produce the required
H2O2 in the presence of catalytic amounts of Fe(II),
30 our results
suggest that phosphorylation at either Y125 or S129 could
inﬂuence Fe(II)-dependent α-syn toxicity via an increased
release of hydroxyl radicals. Owing to the proximity of these
residues, the present study also highlights the need to study
potential cross-talk between phosphorylation sites.
Phosphorylation of α-syn(107140) Leads to a Shift in
Binding Sites of Metal Ions from the N-Terminus to C-
Terminus. Similar to the comparisons of the C-terminal α-syn
fragments with and without metal bindings present in tandem
mass spectra (see the Supporting Information), the binding sites
Table 1. Dissociation Constants (Kd) and the Metal Binding Numbers Per Peptide (n) of the Complexes of Metal Ions and Wild
Type and Phosphorylated α-syn(107-140)
Cu(II) Pb(II) Fe(II) Fe(III)
α-syn (107140) Kd/μM n Kd/μM n Kd/μM n Kd/μM n
wt 203( 7 1.9( 0.1 240( 12 1.7( 0.1 72( 3 1.5 ( 0.1 52( 3 1.8( 0.1
pY125 176( 6 1.8 ( 0.1 187( 5 3.2( 0.3 47( 6 1.8( 0.5 46( 2 1.7( 0.1
pS129 160( 10 1.8( 0.2 83 ( 16 1.0( 0.2 45( 3 2.2( 0.3 50( 3 1.8 ( 0.1
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of Cu(II), Pb(II), Fe(II), and hydrated iron oxide complexes to
phosphorylated α-syn(107140) were identified. Figure 3 clearly
shows that the phosphorylations at Y125 and S129 influence the
binding sites of metal ions significantly. For example, in Cu(II)
binding, residues P128S129 were involved in the coordination
of the wt but not the pY125 peptide. Moreover, compared to the
wt binding sites, there was an obvious shift in the Cu(II) binding
sites of phosphorylated α-syn(107140) from the N-terminus
to the C-terminus, where the phosphorylated amino acids of both
pY125 and pS129 were located. In the cases of the Pb(II) and
Fe(II) bindings, the residue D119 participates in the binding of
these metal ions to the wt peptide, but not in the binding of both
pY125 and pS129. Instead, residue Y125 was only implicated in
metal binding of the phosphorylated pY125 and peptides.
Furthermore, the different positions of phosphorylated residues
on α-syn(107140) appear to have different effects on the bind-
ing sites. Meanwhile, the binding sites of metal ions to pS129 also
displayed a similar shift from the N-terminus to the C-terminus
compared to the binding sites of pY125. In the case of Pb(II),
residues E131-Y133 were involved in the binding of Pd (II) to
pS129, but not to pY125. Conversely, the residues within N122-
A124 were highly implicated in the binding of Pd(II) to pY125,
but not to pS129. In the case of Fe(III) (in fact [Fe2O4H2]
+)
binding, residues E126-E131 complemented the possible bind-
ing sites for pS129 beside these binding regions (P120Y125)
already involved in pY125. Overall, we observed that phosphor-
ylations at Y125 and S129 ofα-syn(107140) lead to the shift of
the binding sites of metal ions from the N-terminus to C-teminus.
To clearly illustrate the binding shift induced by phosphoryla-
tion, the possible binding modes of Fe(II) to peptides according
to the results of the tandem MS were deduced and drawn
schematically in Figure 4. We assume the coordination number
of Fe(II) to be four and to involve the oxygen atoms of side
chains, e.g., carboxylates, phosphates, and deprotonated phenols.
As shown in Figure 4, the binding site nearest theN-terminus of a
wt peptide bound to Fe(II) is D119 instead of E123 in pY125 and
E126 in pS129, and the binding site nearest to the C-terminus of
pY125 is E130 instead of E131 in pS129 or S129 in wt. Thus, the
binding sites of Fe(II) to wt are located closer to the N-terminus
than those for phosphorylated α-syn(107140), and the puta-
tive coordinated residues of pS129 were closer to the C-terminus
compared to pY125. The relocations of the binding sites and
stronger aﬃnities of metal ions to the phosphorylated peptides
strongly suggest that phosphorylation at the C-terminus may
play an important role in regulating metal ion binding, and both
of these modiﬁcations could signiﬁcantly inﬂuence α-syn struc-
ture and aggregation, and alter its functional and toxic properties.
In the present work, we investigated the binding features of
Cu(II), Pb(II), Fe(II), and Fe(III) to C-terminal α-syn(107140)
and the eﬀects of phosphorylation on the metal binding. ESI-MS
is a powerful tool to study bioinorganic complexes and provides
detailed information on the compositions and structures of the
complexes. Here, owing to the analysis of tandem MS data, the
sequence D115-M116 was ﬁrst identiﬁed to be involved in
Cu(II) binding. Besides the region D119-A124, which is com-
monly believed to be involved in the divalent metal ions’
binding,6 the sequence P128-S129 was also found to be involved
in the binding with Cu(II), Pb(II), and Fe(II). This new observa-
tion increased the correlative residues that could induce the
conformation change of C-terminal α-syn and could contribute
to the eﬀect of metal ions on α-syn aggregation. A hydrated iron
oxide complexwithwild type and phosphorylatedα-syn(107140)
was determined by ESI-MS instead of Fe(III)-peptides com-
plexes, and they displayed a much higher binding aﬃnity than
other metal ions, as revealed by intrinsic tyrosine ﬂuorescence.
This unexpected observation explained the absence of the
complexes of Fe(III) and full-length α-syn by ESI-MS reported
by Zhou et al.44 and makes it necessary to revaluate the so-called
“Fe(III)”-induced aggregation of α-syn in vitro. The dissociation
constants, measured by intrinsic tyrosine ﬂuorescence spectros-
copy, displayed the enhancement of binding aﬃnities of metal
ions to phosphorylated α-syn(107140) compared with wild
type.Moreover, we demonstrate here that the phosphorylation at
Y125 and S129 inﬂuenced not only the binding aﬃnities but also
the locations of binding sites. Tandem MS data showed the
migration of the binding site of each metal ion toward the site of
phosphorylation. These changes in the binding properties of
phosphorylated α-syn(107140) to metal ions may lead to an
alteration in the metal-induced conformational changes of the
C-terminus of α-syn and its aggregation properties. Our results
expand our understanding of the molecular and structural
mechanisms underlying the interactions between α-syn and
metal ions, including the identiﬁcation of novel metal binding sites,
and highlight the potential importance of cross-talk between post-
translational modiﬁcations and metal ion binding in regulating
α-syn physiological functions and aggregation properties that are
Figure 4. Possible modes of Fe(II) coordinating to wild type (wt) and phosphorylatedα-syn(107140) (pY125 and pS129) schematically drawn using
software PyMol.49
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regulated by its C-terminal domain. Indeed, a recent in vivo study
by Chen and colleagues highlighted that phosphorylation at
Y125 could counteract pS129-dependent neurotoxicity in a
Drosophila model of Parkinson’s disease.50
’METHODS
Chemicals. Cupric chloride dihydrate (CuCl2 3 2H2O), ferrous sulfate
heptahydrate (Fe(SO4)2 3 7H2O), ferric chloride anhydrous (FeCl3), lead-
(II) nitrate (Pb(NO3)2), N-methylpyrrolidone (NMP), and 32% hydro-
chloric acid were bought from Acros Organics (Geel, Belgium). Methanol
(MeOH) was from Riedel-de-Ha€en (Seelze, Germany). Deionized water
(18.2 MΩ 3 cm) was obtained from a Milli-Q system from Millipore
(Bedford,MA).HBTU (O-benzotriazole-N,N,N0,N0-tetramethyl-uronium-
hexafluorophosphate), dimethylformamide (DMF), triisopropylsilane
(TIPS), diethyl ether, and acetonitrile were purchased from AnaSpec Inc.
(Fremont, California). 1,2-Ethanedithiol (EDT), N,N-diisopropylethyla-
mine (DIPEA), thioanisole, trifluoroacetic acid (TFA), and dimethylsulfide
were obtained from Sigma (St. Louis, MO).
Peptide Synthesis. Solid phase peptide synthesis (SPPS) was
performed on an automated CS 336X peptide synthesizer from CS Bio
using standard Fmoc protocols including the in situ neutralization protocol
developed by Schn€olzer et al.51 α-syn C-terminal peptides (see list below)
were synthesized on a Wang resin with the first Fmoc-Ala amino acid
preloaded, with a substitution of 0.40.5 mmol/g. Syntheses were carried
out at 0.2 mmol scale, and coupling steps were performed with 5 equiv of
Fmoc-amino acid, 5 equiv of HBTU, and 5 equiv of DIPEA in NMP.
Simultaneous peptide side-chain deprotection and cleavage from theWang
resin was performed by treatment with Reagent H52 (81:5:3:5:2.5:2:1.5
TFA/phenol/H2O/thioanisole/EDT/Me2S/NH4I), twice for 2 h with
diethyl ether precipitation after each treatment with Reagent H, in order
to generate peptides with a C-terminal acid functionality while avoiding
methionine oxidation to the sulfoxide or sulfone form (M116 and M127).
After the last diethyl ether precipitation, the crude products were dissolved
in 50% aqueous acetonitrile containing 0.1%TFA, and lyophilized. Peptides
were then purified by reversed-phase HPLC (Waters, Milford, MA) using
either a Vydac or a Phenomenex C18 preparative column (20 250 mm,
5 μm particle size, and 300 Å pore size) and a linear gradient of 050% of
solvent B in solventAover 40min at 10mL/min,where solventAwaswater
with 0.1% TFA and solvent B was acetonitrile with 0.1% TFA. Peptide
elution was monitored by UV absorption at both 214 and 280 nm.
Peptide masses were conﬁrmed byMALDI-TOF-MS (4800MALDI-
TOF/TOF analyzer, ABSciex, Foster City, California) operating in linear
negative ionization mode or by ESI-MS on a Thermo LCQ Fleet (Thermo
Scientiﬁc, San Jose, CA) operated in positive ionization mode (lower-
quality data was obtained using the negative ionization mode on that
system). Peptide purity was assessed by reinjection of the pure material
after lyophilization on a Vydac C18analytical column.
The sequences of the C-terminal α-synuclein(107140) fragments
prepared are
α-synð107 140Þ ðwtÞ
APQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA
α-synð107 140Þ ðpS129Þ
APQEGILEDMPVDPDNEAYEMPpSEEGYQDYEPEA
α-synð107 140Þ ðpY125Þ
APQEGILEDMPVDPDNEApYEMPSEEGYQDYEPEA
mutant α-synð107 140ÞðD119AÞ
APQEGILEDMPVAPDNEAYEMPSEEGYQDYEPEA
where pS and pY indicate phosphoserine and phosphotyrosine, respec-
tively. The puriﬁed, lyophilized peptides were dissolved in deionized
water at a ﬁnal concentration of 1 mg/mL, which were further conﬁrmed
by UV absorption spectroscopy using a Cary 100 Bio UVvis spectro-
photometer (Varian, CH). The molar extinction coeﬃcients used were
2841 M1 3 cm
1 at 267 nm pY125 and 4470 M1 3 cm
1 at 280 nm for
wt and pS129. These stock solutions were aliquoted and stored at
20 C. The stock solution of CuCl2 and Pb(NO3)2 were dissolved in
deionized water at a concentration of 10mM, 100 mM, or 1M, while the
same concentrations of FeCl3 stock solution were prepared in 10 mM
HCl solution in deionized water.
Intrinsic Tyrosine Fluorescence. Fluorescence measurements
were carried out in a rectangular 1 cm quartz cuvette using an LS 55
luminescence spectrometer (PerkinElmer, Waltham, MA). The excita-
tion was set to 280 nm, and the emission spectra were recorded from 290
to 420 nm (emission slit, 6.0 nm; excitation slit, 4.0 nm; scan speed,
500 nm/min; accumulation, 3). Peptides were dissolved at approxi-
mately 5 μM in a 10 mM Tris-HCl buffer at pH 7.4. Metal ions were
added from stock solutions (10 mM, 100 mM, and 1 M) to get final
concentrations ranging from 0 to 3 mM. All experiments were repeated
independently three times.
The maximum tyrosine ﬂuorescence was monitored at 309 nm and
corrected from background induced by the Tris-HCl buﬀer pH 7.4, in
the presence and absence of metal salts. The maximum ﬂuorescence was
normalized and plotted in log scale as a function of the metal ion
concentration. Dissociation constants were obtained by ﬁtting the data
(using the software IgorPro 6.0, WaveMetrics Inc., Tigard, OR)
according to the following equation:
Fð½MÞ ¼ a þ b ½M
c
 n !
= 1 þ ½M
c
 n !
ð1Þ
where [M] stands for the metal ion concentration in μM, F for the
ﬂuorescence, a and b for the ﬂuorescence at [M] = 0 and∞, respectively,
c for Kd in μM, and n for the number of binding sites.
Mass Spectrometry. An LTQ ion trap mass spectrometer
(Thermo Scientific, San Jose, CA) was used in the analyses of the
peptides and metalpeptide complexes, and all data were collected in
positive ionization mode. The commercial heated electrospray ioniza-
tion interface was used and the heated transfer capillary was kept at
275 C. The applied high voltage was set at 4.0 kV, and the sample was
infused at 3.5 μL/min. The ion optics parameters were kept constant for
each experiment. Peptide solutions for theMS analyses were diluted to a
final concentration of 5 μM in 50/50 MeOH/H2O (v/v) before each
experiment. Aliquots ofmetals were added into peptide solutions and gently
mixed with a micropipet, and then incubated for at least 10 min at room
temperature before being diluted with 50/50 MeOH/H2O (v/v) to a final
peptide concentration of 5 μM before the MS analysis. All solutions were
prepared fresh daily. The fragments generated in MS/MS were assigned
based on the calculations of the web-based software, MS-Products from
UCSF (http://prospector.ucsf.edu/prospector/mshome.htm).
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